All You Need to Know on the Ecuador Sessions 2020

After 3 years, SOLACI returns to Ecuador -this time to the beautiful city of Manta- to continue promoting the development of interventional cardiology in Latin America. Do not hesitate to participate in this important event that will undoubtedly be enriching for medical practice and, also, to improve the quality of life of patients in our region.

Jornadas Ecuador 2020

Below you will find all the relevant information you need to know about the Ecuador Regional Sessions 2020.

When?

March 6th & 7th, 2020.

Where?

They will take place in Manta, Ecuador. (Oro Verde Hotel).

How can I register?

By entering HERE.

Which are the registrations fees?

  • Specialists | USD 160.
  • Generales Physicians | USD 130.
  • Students | USD 100.
  • Technicians & Nurses | USD 80.

Scientific Program

Access the scientific program

Which are the relevant topics?

  • Acute Coronary Syndrome
  • Coronary interventionism.
  • Aortic Valve Interventions.
  • Mitral valve.
  • Antithrombotic Therapy
  • Atrial Fibrillation Intervention.
  • Pediatric intervention.
  • Live cases.
  • Clinical Case Contest for Young Interventionists
  • Imagen Contest.

Who are organizing these sessions?

The Latin American Society of Interventional Cardiology alongside with the Ecuadorian Society of Cardiovascular Interventions (SEICAV).

Contact

¿En qué consiste el Concurso de Imágenes?

It is an interactive activity consisting in the presentation of a case series based on imaging. One or more multiple-choice questions will be asked regarding these cases. Participants will send their answers through their smartphones, which will connect to the evaluation information system. The Contest will also include a few questions on general knowledge for entertainment purposes. The participant with more correct answers will be the winner. Its first price will be the fee for full registration, lodging and transportation costs to Chile Sessions 2016 (November 30th and December 1st).

What are the winners of the Imaging and Clinical Case Contests awarded?

All costs to some of the next SOLACI Sessions will be waived.

SOLACI Board

Jornadas SOLACI Director
Dr. Mario Araya (Chile).

Jornadas SOLACI Vice Director
Dr. Gustavo Vignolo (Uruguay).

SOLACI Sessions Scientific Committee Director
Dr. Marcio Montenegro (Brasil).

SEICAV Board

SEICAV President
Dr. Gustavo Hidalgo.

SEICAV Vice President
Dr. José Vivas Guijarro.

SEICAV Secretary
Dr. Alfonso Zambrano.

 SEICAV Pro-secretary
Dr. Wishton Moreira.

SEICAV Vocal
Dr. Ricardo Ortíz.

SEICAV Vocal
Dr. Erwin Téllez.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACC 2026: SURViV Trial Results – Exclusive Presentation and Analysis with Dr. Dimytri Siqueira

Following the presentation of the SURViV trial in the Late Breaking Clinical Trials sessions at the American College of Cardiology Congress, Dr. Dimytri Siqueira...

SOLACI Technicians Webinar – Ultrasound Pulses + Calcium = Coronary Lithotripsy

The Latin American Society of Interventional Cardiology (SOLACI) invites you to participate in a new Live SOLACI Webinar specially designed for technicians, nurses, and...

COMPLICAT 2026: Collaborative learning to address complications in congenital and structural heart disease

Free online course in Spanish5 webinars in 2026 COMPLICAT 2026 returns with its second edition, consolidating itself as an innovative academic space dedicated to the...

CHIP LATAM | Chapter 2 – Mexico: Complications Workshop

The Latin American Society of Interventional Cardiology invites the entire medical community to participate in a virtual workshop on complications organized by SOLACI’s Complex...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...